Cargando…

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach

A year after the initial outbreak, the COVID-19 pandemic caused by SARS-CoV-2 virus remains a serious threat to global health, while current treatment options are insufficient to bring major improvements. The aim of this study is to identify repurposable drug candidates with a potential to reverse t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelemanović, Andrea, Vidović, Tinka, Stepanić, Višnja, Trajković, Katarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912585/ https://www.ncbi.nlm.nih.gov/pubmed/33504008 http://dx.doi.org/10.3390/ph14020087

Ejemplares similares

A method for the rational selection of drug repurposing candidates from multimodal knowledge harmonization
por: Schultz, Bruce, et al.
Publicado: (2021)

Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
por: Islam, Tania, et al.
Publicado: (2020)

Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
por: Sakai, Norihiro, et al.
Publicado: (2023)

Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates
por: Roundhill, Elizabeth Ann, et al.
Publicado: (2023)

Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing
por: Bernal, Leonardo, et al.
Publicado: (2023)

Repurposing of Drug Candidates for Treatment of Skin Cancer
por: Cortés, Hernán, et al.
Publicado: (2021)

Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
por: Tuan, Nguyen Minh, et al.
Publicado: (2019)

Systematically Prioritizing Candidates in Genome-Based Drug Repurposing
por: Challa, Anup P., et al.
Publicado: (2019)

Transcriptomics-Guided In Silico Drug Repurposing: Identifying New Candidates with Dual-Stage Antiplasmodial Activity
por: Borba, Joyce V. B., et al.
Publicado: (2023)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Transcriptome-Guided Identification of Drugs for Repurposing to Treat Age-Related Hearing Loss
por: Schubert, Nick M. A., et al.
Publicado: (2022)

Model‐informed drug repurposing: Viral kinetic modelling to prioritize rational drug combinations for COVID‐19
por: Dodds, Michael G., et al.
Publicado: (2020)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Towards Drug Repurposing in Cancer Cachexia: Potential Targets and Candidates
por: Santos, Joana M. O., et al.
Publicado: (2021)

Drug repurposing for COVID-19: Approaches, challenges and promising candidates
por: Ng, Yan Ling, et al.
Publicado: (2021)

Systematic Down-Selection of Repurposed Drug Candidates for COVID-19
por: MacRaild, Christopher A., et al.
Publicado: (2022)

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021)

Application of the PHENotype SIMulator for rapid identification of potential candidates in effective COVID-19 drug repurposing
por: Maria, Naomi I., et al.
Publicado: (2023)

Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022)

Validation of transcriptome signature reversion for drug repurposing in oncology
por: Koudijs, Karel K M, et al.
Publicado: (2022)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

Framework for identifying drug repurposing candidates from observational healthcare data
por: Ozery-Flato, Michal, et al.
Publicado: (2020)

Repurposing Cannabidiol as a Potential Drug Candidate for Anti-Tumor Therapies
por: Wang, Fei, et al.
Publicado: (2021)

Drug repurposing candidates to treat core symptoms in autism spectrum disorder
por: Koch, Elise, et al.
Publicado: (2022)

Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023)

Tebrophen — An Old Polyphenol Drug with Anticancer Potential (†)
por: Rubelj, Ivica, et al.
Publicado: (2012)

Heterogeneity in the Identification of Potential Drug‐Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations
por: Bakker, Tinka, et al.
Publicado: (2022)

Identification of drug repurposing candidates based on a miRNA-mediated drug and pathway network for cardiac hypertrophy and acute myocardial infarction
por: Sun, Jiantao, et al.
Publicado: (2018)

Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products
por: Stepanić, Višnja, et al.
Publicado: (2023)

Redox Active Molecules in Cancer Treatments
por: Stepanić, Višnja, et al.
Publicado: (2023)

Transcriptome analysis uncovers the key pathways and candidate genes related to the treatment of Echinococcus granulosus protoscoleces with the repurposed drug pyronaridine
por: Yu, Yingfang, et al.
Publicado: (2021)

Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
por: Liang, Shuang, et al.
Publicado: (2023)

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020)

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017)

Scaffold Searching of FDA and EMA-Approved Drugs Identifies Lead Candidates for Drug Repurposing in Alzheimer’s Disease
por: Shityakov, Sergey, et al.
Publicado: (2021)

Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
por: Sharma, Khushbu, et al.
Publicado: (2023)

Construction of miRNA-regulated drug-pathway network to screen drug repurposing candidates for multiple sclerosis
por: Kong, Xiaotong, et al.
Publicado: (2022)

Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis
por: Rajput, Akanksha, et al.
Publicado: (2021)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
por: Moreira-Silva, Filipa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cnduk1e11dq2dnrtrrl20emoq0